Cartesian Therapeutics (RNAC) FCF Margin (2015 - 2026)
Cartesian Therapeutics' FCF Margin came in at -28412.82% for Q1 2026, down 26214.37 percentage points from -2198.45% a year earlier and down 26490.54 percentage points from the prior quarter.
Cartesian Therapeutics (RNAC) FCF Margin (2015 - 2026) Analysis & Trends
For FY2025, Cartesian Therapeutics' FCF Margin was -2838.58%, down 2754.37 percentage points from FY2024.
- FCF Margin carries a five-year change of -3043.83 percentage points (FY2020 to FY2025).
- Going back by year, FCF Margin was -84.21% in FY2024 (+113.33 pp), -197.53% in FY2023 (-167.90 pp), -29.64% in FY2022 (+42.61 pp) and -72.25% in FY2021 (-277.50 pp).
- The Q1 2026 figure represents the lowest quarterly FCF Margin since Q2 2019.
- Year-over-year, FCF Margin increased in two of the last six quarters, with an average year-over-year change of -6381.34 percentage points.
- The fastest year-over-year change in FCF Margin over five years came in Q3 2024 (a gain of 2076.58 percentage points), and the weakest in Q1 2026 (a drop of 26214.37 percentage points).
- Business Quant data shows RNAC's FCF Margin at -1922.28% (Q4 2025), -3737.17% (Q3 2025) and -6750.34% (Q2 2025) in the three quarters before Q1 2026.
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | FCF Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 655.56 Bn | 574.09 Bn | 17.26 Bn | 28.82% |
| 2 | AbbVie | 470.94 Bn | 444.10 Bn | 12.70 Bn | 18.33% |
| 3 | Merck | 367.14 Bn | 321.57 Bn | 12.21 Bn | 26.96% |
| 4 | Novartis Ag | 280.33 Bn | 236.20 Bn | 11.24 Bn | 43.05% |
| 5 | Astrazeneca | 257.78 Bn | 231.34 Bn | 12.86 Bn | 34.72% |
| 6 | Amgen | 226.04 Bn | 181.44 Bn | 7.24 Bn | 34.70% |
| 7 | Gilead Sciences | 188.89 Bn | 163.01 Bn | 6.22 Bn | 44.00% |
| 8 | Pfizer | 163.75 Bn | 110.70 Bn | 10.94 Bn | 2.01% |
| 9 | Vertex Pharmaceuticals | 133.68 Bn | 105.69 Bn | 2.84 Bn | 30.39% |
| 10 | Cartesian Therapeutics | 216.57 Mn | 216.57 Mn | - | - |
Historic Data
| Date | Value |
|---|---|
| Mar 31, 2026 | -28,412.82% |
| Dec 31, 2025 | -1,922.28% |
| Sep 30, 2025 | -3,737.17% |
| Jun 30, 2025 | -6,750.34% |
| Mar 31, 2025 | -2,198.45% |
| Sep 30, 2024 | 1,935.92% |
| Jun 30, 2024 | -47.94% |
| Mar 31, 2024 | -282.86% |
| Dec 31, 2023 | -282.48% |
| Sep 30, 2023 | -140.67% |
| Jun 30, 2023 | -188.74% |
| Mar 31, 2023 | -149.80% |
| Dec 31, 2022 | -71.81% |
| Sep 30, 2022 | 18.91% |
| Jun 30, 2022 | -31.50% |
| Mar 31, 2022 | -36.23% |
| Dec 31, 2021 | -106.02% |
| Sep 30, 2021 | -44.66% |
| Jun 30, 2021 | -33.88% |
| Mar 31, 2021 | -110.03% |
Cartesian Therapeutics FCF Margin API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=fcf-margin&ticker=RNAC&period=max&api_key=YOUR_API_KEY
import requests
url = "https://data.businessquant.com/historic"
params = {"slug": "fcf-margin", "ticker": "RNAC", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()
const res = await fetch("https://data.businessquant.com/historic?slug=fcf-margin&ticker=RNAC&period=max&api_key=YOUR_API_KEY");
const data = await res.json();